Zpeer Unveils A-DHA-PT™ High-Concentration DHA Supplement For Dogs and Partners with University of Tokyo
Zpeer Inc., based in Shibuya, Tokyo, is making headlines with the launch of their new product A-DHA-PT™ (pronounced 'ay-dapt'), a high-concentration DHA supplement designed specifically for dogs. This innovative supplement aims to support canine neurological health, an area that has seen rising interest in veterinary medicine.
Each capsule of A-DHA-PT™ contains over 150 mg of DHA, enabling effective delivery of essential nutrients while minimizing the burden of pill administration for dogs. With a compact size of 13 mm, the product ensures that pet owners can easily provide their pets with the necessary dosage without causing distress. The product is packaged in bags containing 120 capsules, making it convenient for pet owners to incorporate into their pets' daily routine.
The formulation of A-DHA-PT™ is based on previous academic studies that have explored the benefits of DHA supplementation for dogs, particularly those suffering from idiopathic epilepsy. Notably, the product comes under the scientific guidance of Dr. Tomohiro Yonezawa, an Associate Professor at the University of Tokyo, who has been instrumental in the research and understanding of nutritional interventions for canine health. All manufacturing processes adhere to stringent quality and safety standards, utilizing pharmaceutical-grade raw materials sourced in Japan.
In conjunction with the product launch, Zpeer Inc. has initiated a significant research collaboration with the University of Tokyo. This partnership aims to investigate the clinical benefits of DHA supplementation for dogs with epilepsy. The research agreement, which began on November 27, 2025, will focus on generating comprehensive clinical evidence through structured studies that assess seizure outcomes and quality of life in dogs affected by this neurological condition.
According to Dr. Yonezawa, previous observations suggested that DHA might play a crucial role in managing seizure frequency in dogs. However, numerous clinical questions remain unanswered, and this collaboration intends to address those gaps by providing a systematic evaluation of DHA's effects in real-world clinical settings. The insights gained from this research will contribute to the evolving field of veterinary neurology, potentially leading to better management strategies for canine epilepsy and other neurological disorders.
A-DHA-PT™ products will be sold through Zpeer’s veterinary e-commerce platform, Animato, which connects pet owners with vet-endorsed products. A key feature of purchasing A-DHA-PT™ is that owners must register their primary veterinary clinic to ensure that the wellbeing of their pet is prioritized in every aspect of care.
Zpeer Inc. is dedicated to developing therapeutic solutions that leverage clinical evidence and research to enhance animal health. Their innovative approach not only aims to improve the quality of life for pets but also supports veterinary professionals in their commitment to high standards of care.
For more information about A-DHA-PT™ and their other offerings, visit the official Zpeer website at https://zpeer.info/en/
Each capsule of A-DHA-PT™ contains over 150 mg of DHA, enabling effective delivery of essential nutrients while minimizing the burden of pill administration for dogs. With a compact size of 13 mm, the product ensures that pet owners can easily provide their pets with the necessary dosage without causing distress. The product is packaged in bags containing 120 capsules, making it convenient for pet owners to incorporate into their pets' daily routine.
The formulation of A-DHA-PT™ is based on previous academic studies that have explored the benefits of DHA supplementation for dogs, particularly those suffering from idiopathic epilepsy. Notably, the product comes under the scientific guidance of Dr. Tomohiro Yonezawa, an Associate Professor at the University of Tokyo, who has been instrumental in the research and understanding of nutritional interventions for canine health. All manufacturing processes adhere to stringent quality and safety standards, utilizing pharmaceutical-grade raw materials sourced in Japan.
In conjunction with the product launch, Zpeer Inc. has initiated a significant research collaboration with the University of Tokyo. This partnership aims to investigate the clinical benefits of DHA supplementation for dogs with epilepsy. The research agreement, which began on November 27, 2025, will focus on generating comprehensive clinical evidence through structured studies that assess seizure outcomes and quality of life in dogs affected by this neurological condition.
According to Dr. Yonezawa, previous observations suggested that DHA might play a crucial role in managing seizure frequency in dogs. However, numerous clinical questions remain unanswered, and this collaboration intends to address those gaps by providing a systematic evaluation of DHA's effects in real-world clinical settings. The insights gained from this research will contribute to the evolving field of veterinary neurology, potentially leading to better management strategies for canine epilepsy and other neurological disorders.
A-DHA-PT™ products will be sold through Zpeer’s veterinary e-commerce platform, Animato, which connects pet owners with vet-endorsed products. A key feature of purchasing A-DHA-PT™ is that owners must register their primary veterinary clinic to ensure that the wellbeing of their pet is prioritized in every aspect of care.
Zpeer Inc. is dedicated to developing therapeutic solutions that leverage clinical evidence and research to enhance animal health. Their innovative approach not only aims to improve the quality of life for pets but also supports veterinary professionals in their commitment to high standards of care.
For more information about A-DHA-PT™ and their other offerings, visit the official Zpeer website at https://zpeer.info/en/
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.